Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1877-2025

BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems Recall

BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems

FDA recall Class II

Ongoing

FDA lists this Class II recall for BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1877-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 30, 2025
FDA report date
Jun 4, 2025
Quantity in commerce
30 kits
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems

Affected model & UDI checker

Search the exact identifiers published for Z-1877-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
423740BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systemsCheck source noticeNot specified
FDA code information

Lot# 1475424/ UDI: None

View the original FDA recall notice

Why was this product recalled?

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Biofire Diagnostics, LLC take?

On April 30, 2025, Biomerieux issued a "Urgent Field Safety Notice" to affected consignees via email. Biomerieux asked consignees to take the following actions: 1. Immediately examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. As previously confirmed discontinued use of product, please confirm the amount of kits destroyed on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology